Your browser doesn't support javascript.
loading
Kidney transplant recipients' attitudes toward COVID-19 vaccination and barriers and enablers to vaccine acceptance.
Tharmaraj, Dhakshayini; Dendle, Claire; Polkinghorne, Kevan R; Mulley, William R.
Afiliação
  • Tharmaraj D; Department of Nephrology, Monash Health, Clayton, Victoria, Australia.
  • Dendle C; Department of Medicine, Centre for Inflammatory Diseases, Monash University, Clayton, Victoria, Australia.
  • Polkinghorne KR; Department of Medicine, Centre for Inflammatory Diseases, Monash University, Clayton, Victoria, Australia.
  • Mulley WR; Department of Infectious Diseases, Monash Health, Clayton, Victoria, Australia.
Transpl Infect Dis ; 24(1): e13749, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34694682
ABSTRACT

OBJECTIVE:

To identify barriers and enablers to COVID-19 vaccination in renal transplant recipients who are undecided about vaccination.

METHODS:

An online survey was distributed to 876 adult kidney transplant recipients at a tertiary referral service, who had not been vaccinated against COVID-19. The survey assessed willingness to be vaccinated, attitudes toward COVID-19 vaccines, and barriers and enablers to proceeding with vaccination.

RESULTS:

The survey response rate was 54% (473/876). Three hundred and forty-six (73.1%) participants planned to receive vaccination (yes group), 105 (22.2%) were undecided, and 22 (4.7%) refused vaccination. The undecided group were younger but were not different in other demographic characteristics to the yes group. The undecided group were less positive toward (34.29% vs. 91.3%, p < .001) and more concerned about (93.3% vs. 25.1%, p < .001) vaccination than the yes group. Their concerns related to vaccine safety (including harm to their transplant), poor efficacy, and a lack of rigorous testing in transplant recipients. Undecided recipients had received less vaccine-specific information from medical specialists than the yes group. Most undecided participants (95.1%) were willing to proceed with vaccination with appropriate supports. The most desired supports were information and a recommendation to proceed with vaccination from their treating transplant specialist and team. CONCLUSION(S) Concerns about vaccine safety (including harm to transplant), poor vaccine efficacy, and lack of rigorous testing were barriers to vaccine uptake. Most undecided recipients would proceed with vaccination with specific recommendations and vaccine information provided by their transplant specialist/team. These simple interventions can be readily implemented to optimize vaccine uptake.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Transplante de Rim / COVID-19 Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Transpl Infect Dis Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Transplante de Rim / COVID-19 Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Transpl Infect Dis Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália